Summary
The global 5-Aminosalicylic Acid market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
High Purity
Low Purity
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Taj Pharmaceuticals Ltd
Cambrex
Sunflower
Hubei Ocean Biotech Co., Ltd
Lasa Loboratory
ALP PHARM BEIJING CO LTD, CHINA
BAYER PHARMA AG, GERMANY
CADILA HEALTHCARE LTD, INDIA
CHEMI SPA, ITALY
CILAG CHEMIE AG, SWITZERLAND
CORDEN PHARMA BERGAMO SPA, ITALY
CTX LIFE SCIENCES PVT LTD, INDIA
DEAFARMA, Italy
DIVIS LABORATORIES LTD, INDIA
DK Pharmachem Pvt. Ltd, India
DR REDDYS LABORATORIES LTD, INDIA
EASTMAN CHEMICAL CO, UNITED STATES
ERREGIERRE SPA, ITALY
INFAR SA, SPAIN
IPCA LABORATORIES LTD, INDIA
LUPIN LTD, INDIA
PharmaZell (Vizag) Private Limited, JAPAN
PHARMAZELL GMBH, GERMANY
PLIVA CROATIA LTD, Croatia
SIGMA F AND D DIV LTD, UNITED STATES
SIMS SRL, ITALY
SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA
SYNTESE AS, DENMARK
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
WAITAKI INTERNATIONAL
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Enteric-coated Tablets Product
Capsule Product
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 5-Aminosalicylic Acid of Research
1.1.1 Definition
1.1.2 Specifications of 5-Aminosalicylic Acid
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 High Purity Overview
1.2.1.2 Low Purity Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Enteric-coated Tablets Product
1.3.1.2 Capsule Product
1.3.1.3 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 High Purity Market Size 2018-2023
3.1.1.1 Global High Purity Market Size and Growth Rate 2018-2023
3.1.1.2 Global High Purity Market Size by Region 2018-2023
3.1.2 Low Purity Market Size 2018-2023
3.1.2.1 Global Low Purity Market Size and Growth Rate 2018-2023
3.1.2.2 Global Low Purity Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 High Purity Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global High Purity Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global High Purity Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Low Purity Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Low Purity Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Low Purity Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Enteric-coated Tablets Product Market Size 2018-2023
4.1.1.1 Global Enteric-coated Tablets Product Market Size and Growth Rate 2018-2023
4.1.1.2 Global Enteric-coated Tablets Product Market Size by Region 2018-2023
4.1.2 Capsule Product Market Size 2018-2023
4.1.2.1 Global Capsule Product Market Size and Growth Rate 2018-2023
4.1.2.2 Global Capsule Product Market Size by Region 2018-2023
4.1.3 Others Market Size 2018-2023
4.1.3.1 Global Others Market Size and Growth Rate 2018-2023
4.1.3.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Enteric-coated Tablets Product Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Enteric-coated Tablets Product Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Enteric-coated Tablets Product Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Capsule Product Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Capsule Product Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Capsule Product Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Others Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global 5-Aminosalicylic Acid Market Competition
7.1.1 Global 5-Aminosalicylic Acid Market by Companies
7.1.2 Global 5-Aminosalicylic Acid Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Taj Pharmaceuticals Ltd
8.1.1 Taj Pharmaceuticals Ltd Company Profile
8.1.2 Taj Pharmaceuticals Ltd Product Portfolio
8.1.3 Taj Pharmaceuticals Ltd Business Performance
8.1.4 Taj Pharmaceuticals Ltd Development Overview
8.2 Cambrex
8.2.1 Cambrex Company Profile
8.2.2 Cambrex Product Portfolio
8.2.3 Cambrex Business Performance
8.2.4 Cambrex Development Overview
8.3 Sunflower
8.3.1 Sunflower Company Profile
8.3.2 Sunflower Product Portfolio
8.3.3 Sunflower Business Performance
8.3.4 Sunflower Development Overview
8.4 Hubei Ocean Biotech Co., Ltd
8.4.1 Hubei Ocean Biotech Co., Ltd Company Profile
8.4.2 Hubei Ocean Biotech Co., Ltd Product Portfolio
8.4.3 Hubei Ocean Biotech Co., Ltd Business Performance
8.4.4 Hubei Ocean Biotech Co., Ltd Development Overview
8.5 Lasa Loboratory
8.5.1 Lasa Loboratory Company Profile
8.5.2 Lasa Loboratory Product Portfolio
8.5.3 Lasa Loboratory Business Performance
8.5.4 Lasa Loboratory Development Overview
8.6 ALP PHARM BEIJING CO LTD, CHINA
8.6.1 ALP PHARM BEIJING CO LTD, CHINA Company Profile
8.6.2 ALP PHARM BEIJING CO LTD, CHINA Product Portfolio
8.6.3 ALP PHARM BEIJING CO LTD, CHINA Business Performance
8.6.4 ALP PHARM BEIJING CO LTD, CHINA Development Overview
8.7 BAYER PHARMA AG, GERMANY
8.7.1 BAYER PHARMA AG, GERMANY Company Profile
8.7.2 BAYER PHARMA AG, GERMANY Product Portfolio
8.7.3 BAYER PHARMA AG, GERMANY Business Performance
8.7.4 BAYER PHARMA AG, GERMANY Development Overview
8.8 CADILA HEALTHCARE LTD, INDIA
8.8.1 CADILA HEALTHCARE LTD, INDIA Company Profile
8.8.2 CADILA HEALTHCARE LTD, INDIA Product Portfolio
8.8.3 CADILA HEALTHCARE LTD, INDIA Business Performance
8.8.4 CADILA HEALTHCARE LTD, INDIA Development Overview
8.9 CHEMI SPA, ITALY
8.9.1 CHEMI SPA, ITALY Company Profile
8.9.2 CHEMI SPA, ITALY Product Portfolio
8.9.3 CHEMI SPA, ITALY Business Performance
8.9.4 CHEMI SPA, ITALY Development Overview
8.10 CILAG CHEMIE AG, SWITZERLAND
8.10.1 CILAG CHEMIE AG, SWITZERLAND Company Profile
8.10.2 CILAG CHEMIE AG, SWITZERLAND Product Portfolio
8.10.3 CILAG CHEMIE AG, SWITZERLAND Business Performance
8.10.4 CILAG CHEMIE AG, SWITZERLAND Development Overview
8.11 CORDEN PHARMA BERGAMO SPA, ITALY
8.11.1 CORDEN PHARMA BERGAMO SPA, ITALY Company Profile
8.11.2 CORDEN PHARMA BERGAMO SPA, ITALY Product Portfolio
8.11.3 CORDEN PHARMA BERGAMO SPA, ITALY Business Performance
8.11.4 CORDEN PHARMA BERGAMO SPA, ITALY Development Overview
8.12 CTX LIFE SCIENCES PVT LTD, INDIA
8.12.1 CTX LIFE SCIENCES PVT LTD, INDIA Company Profile
8.12.2 CTX LIFE SCIENCES PVT LTD, INDIA Product Portfolio
8.12.3 CTX LIFE SCIENCES PVT LTD, INDIA Business Performance
8.12.4 CTX LIFE SCIENCES PVT LTD, INDIA Development Overview
8.13 DEAFARMA, Italy
8.13.1 DEAFARMA, Italy Company Profile
8.13.2 DEAFARMA, Italy Product Portfolio
8.13.3 DEAFARMA, Italy Business Performance
8.13.4 DEAFARMA, Italy Development Overview
8.14 DIVIS LABORATORIES LTD, INDIA
8.14.1 DIVIS LABORATORIES LTD, INDIA Company Profile
8.14.2 DIVIS LABORATORIES LTD, INDIA Product Portfolio
8.14.3 DIVIS LABORATORIES LTD, INDIA Business Performance
8.14.4 DIVIS LABORATORIES LTD, INDIA Development Overview
8.15 DK Pharmachem Pvt. Ltd, India
8.15.1 DK Pharmachem Pvt. Ltd, India Company Profile
8.15.2 DK Pharmachem Pvt. Ltd, India Product Portfolio
8.15.3 DK Pharmachem Pvt. Ltd, India Business Performance
8.15.4 DK Pharmachem Pvt. Ltd, India Development Overview
8.16 DR REDDYS LABORATORIES LTD, INDIA
8.16.1 DR REDDYS LABORATORIES LTD, INDIA Company Profile
8.16.2 DR REDDYS LABORATORIES LTD, INDIA Product Portfolio
8.16.3 DR REDDYS LABORATORIES LTD, INDIA Business Performance
8.16.4 DR REDDYS LABORATORIES LTD, INDIA Development Overview
8.17 EASTMAN CHEMICAL CO, UNITED STATES
8.17.1 EASTMAN CHEMICAL CO, UNITED STATES Company Profile
8.17.2 EASTMAN CHEMICAL CO, UNITED STATES Product Portfolio
8.17.3 EASTMAN CHEMICAL CO, UNITED STATES Business Performance
8.17.4 EASTMAN CHEMICAL CO, UNITED STATES Development Overview
8.18 ERREGIERRE SPA, ITALY
8.18.1 ERREGIERRE SPA, ITALY Company Profile
8.18.2 ERREGIERRE SPA, ITALY Product Portfolio
8.18.3 ERREGIERRE SPA, ITALY Business Performance
8.18.4 ERREGIERRE SPA, ITALY Development Overview
8.19 INFAR SA, SPAIN
8.19.1 INFAR SA, SPAIN Company Profile
8.19.2 INFAR SA, SPAIN Product Portfolio
8.19.3 INFAR SA, SPAIN Business Performance
8.19.4 INFAR SA, SPAIN Development Overview
8.20 IPCA LABORATORIES LTD, INDIA
8.20.1 IPCA LABORATORIES LTD, INDIA Company Profile
8.20.2 IPCA LABORATORIES LTD, INDIA Product Portfolio
8.20.3 IPCA LABORATORIES LTD, INDIA Business Performance
8.20.4 IPCA LABORATORIES LTD, INDIA Development Overview
8.21 LUPIN LTD, INDIA
8.21.1 LUPIN LTD, INDIA Company Profile
8.21.2 LUPIN LTD, INDIA Product Portfolio
8.21.3 LUPIN LTD, INDIA Business Performance
8.21.4 LUPIN LTD, INDIA Development Overview
8.22 PharmaZell (Vizag) Private Limited, JAPAN
8.22.1 PharmaZell (Vizag) Private Limited, JAPAN Company Profile
8.22.2 PharmaZell (Vizag) Private Limited, JAPAN Product Portfolio
8.22.3 PharmaZell (Vizag) Private Limited, JAPAN Business Performance
8.22.4 PharmaZell (Vizag) Private Limited, JAPAN Development Overview
8.23 PHARMAZELL GMBH, GERMANY
8.23.1 PHARMAZELL GMBH, GERMANY Company Profile
8.23.2 PHARMAZELL GMBH, GERMANY Product Portfolio
8.23.3 PHARMAZELL GMBH, GERMANY Business Performance
8.23.4 PHARMAZELL GMBH, GERMANY Development Overview
8.24 PLIVA CROATIA LTD, Croatia
8.24.1 PLIVA CROATIA LTD, Croatia Company Profile
8.24.2 PLIVA CROATIA LTD, Croatia Product Portfolio
8.24.3 PLIVA CROATIA LTD, Croatia Business Performance
8.24.4 PLIVA CROATIA LTD, Croatia Development Overview
8.25 SIGMA F AND D DIV LTD, UNITED STATES
8.25.1 SIGMA F AND D DIV LTD, UNITED STATES Company Profile
8.25.2 SIGMA F AND D DIV LTD, UNITED STATES Product Portfolio
8.25.3 SIGMA F AND D DIV LTD, UNITED STATES Business Performance
8.25.4 SIGMA F AND D DIV LTD, UNITED STATES Development Overview
8.26 SIMS SRL, ITALY
8.26.1 SIMS SRL, ITALY Company Profile
8.26.2 SIMS SRL, ITALY Product Portfolio
8.26.3 SIMS SRL, ITALY Business Performance
8.26.4 SIMS SRL, ITALY Development Overview
8.27 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA
8.27.1 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA Company Profile
8.27.2 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA Product Portfolio
8.27.3 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA Business Performance
8.27.4 SUN PHARMACEUTICAL INDUSTRIES LTD, INDIA Development Overview
8.28 SYNTESE AS, DENMARK
8.28.1 SYNTESE AS, DENMARK Company Profile
8.28.2 SYNTESE AS, DENMARK Product Portfolio
8.28.3 SYNTESE AS, DENMARK Business Performance
8.28.4 SYNTESE AS, DENMARK Development Overview
8.29 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
8.29.1 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL Company Profile
8.29.2 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL Product Portfolio
8.29.3 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL Business Performance
8.29.4 TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL Development Overview
8.30 WAITAKI INTERNATIONAL
8.30.1 WAITAKI INTERNATIONAL Company Profile
8.30.2 WAITAKI INTERNATIONAL Product Portfolio
8.30.3 WAITAKI INTERNATIONAL Business Performance
8.30.4 WAITAKI INTERNATIONAL Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION